The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination

被引:65
作者
Goldblatt, D
Richmond, P
Millard, E
Thornton, C
Miller, E
机构
[1] Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England
[2] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Div Immunisat, London NW9 5EQ, England
[3] Ctr Appl Microbiol Res, Salisbury, Wilts, England
关键词
D O I
10.1086/314901
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The significance of reduced antibody responses to the Haemophilus influenzae type b (Hib) component of acellular pertussis-containing combination vaccines (DTaP-Hib) is unclear. A DTaP-Hib vaccine evaluated in infants vaccinated at ages 2, 3, and 4 months showed reduced anti-Hib polysaccharide IgG (geometric mean concentration [GMC], 1.23 mu g/mL; 57%, >1.0 mu g/mL). Polyribitolribosyl phosphate (PRP) and Hib conjugate (PRP-T) vaccine given as a booster during the second year of life was evaluated for the presence of immunological memory. After boosting, most children achieved anti-PRP IgG >1.0 mu g/mL, although the GMC was higher with PRP-T (88.5 mu g/mL) than with PRP vaccine (7.86 mu g/mL, P < .001). The GMC of the PRP group was higher than anticipated for naive PRP recipients of the same age. PRP-specific IgG avidity was significantly higher after boosting than after priming, providing further evidence for the generation of memory. Despite reduced immunogenicity, DTaP-Hib combination vaccines appear to prime for immunologic memory.
引用
收藏
页码:538 / 541
页数:4
相关论文
共 15 条
[1]   Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines [J].
Anttila, M ;
Eskola, J ;
Åhman, H ;
Käyhty, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06) :1614-1621
[2]   SOMATIC MUTATION AND MEMORY [J].
BEREK, C .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (02) :218-222
[3]   Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants [J].
Dagan, R ;
Eskola, J ;
Leclerc, C ;
Leroy, O .
INFECTION AND IMMUNITY, 1998, 66 (05) :2093-2098
[4]   A RANDOMIZED, PROSPECTIVE FIELD TRIAL OF A CONJUGATE VACCINE IN THE PROTECTION OF INFANTS AND YOUNG-CHILDREN AGAINST INVASIVE HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE [J].
ESKOLA, J ;
KAYHTY, H ;
TAKALA, AK ;
PELTOLA, H ;
RONNBERG, PR ;
KELA, E ;
PEKKANEN, E ;
MCVERRY, PH ;
MAKELA, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (20) :1381-1387
[5]   Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine [J].
Eskola, J ;
Olander, RM ;
Hovi, T ;
Litmanen, L ;
Peltola, S ;
Kayhty, H .
LANCET, 1996, 348 (9043) :1688-1692
[6]   Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization [J].
Goldblatt, D ;
Vaz, ARJPMP ;
Miller, E .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :1112-1115
[7]  
Goldblatt D, 1996, BRIT MED J, V312, P817
[8]  
KAYHTY H, 1984, PEDIATRICS, V74, P857
[9]   Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: Value of laboratory tests as predictors of clinical performance [J].
Miller, E ;
Ashworth, LAE ;
Redhead, K ;
Thornton, C ;
Waight, PA ;
Coleman, T .
VACCINE, 1997, 15 (01) :51-60
[10]  
Nightingale SL, 1998, JAMA-J AM MED ASSOC, V280, P1128, DOI 10.1001/jama.280.13.1128